398 POSTER Phase I, pharmacokinetic (PK), dose-escalation study of EZN-2968, a novel hypoxia-inducible factor-1 alpha (HIF-1a) antagonist, administered weekly in patients (pts) with solid tumours


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Lewis, N; Cohen, RB; Nishida, Y; Hurwitz, HI; Arrowwood, C; Uronis, HE; Gamza, F; Longley, C; Buchbinder, A; Figueroa, J

Published Date

  • October 2008

Published In

Volume / Issue

  • 6 / 12

Start / End Page

  • 125 - 125

Published By

International Standard Serial Number (ISSN)

  • 1359-6349

Digital Object Identifier (DOI)

  • 10.1016/s1359-6349(08)72332-2